All stock lists
Edesa Biotech, Inc. (NASDAQ:EDSA)
Canada · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.57-0.20 (-7.22%)
Insider Score
––Not scored
EDSA Insider Score
Insiders here have filed 3 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
EDSA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 25.64 K | 25.87 K | 25.46 K | 25.87 K | 0.00 | 0.00 |
| Gross Profit | -25.64 K | -25.87 K | -25.46 K | -25.87 K | 0.00 | 0.00 |
| SG&A Expense | 1.56 M | 1.53 M | 1.22 M | 1.24 M | 964.68 K | 1.15 M |
| R&D Expense | 3.96 M | 2.77 M | 1.12 M | 1.23 M | 939.07 K | 484.31 K |
| Operating Expenses | 5.52 M | 4.27 M | 2.32 M | 2.44 M | 1.90 M | 1.64 M |
| Operating Income | -5.52 M | -4.30 M | -2.34 M | -2.47 M | -1.90 M | -1.64 M |
| Pretax Income | -5.41 M | -4.22 M | -2.25 M | -2.23 M | -1.75 M | -1.59 M |
| Tax Provision | 0.00 | 800.00 | 0.00 | 0.00 | 0.00 | 800.00 |
| Net Income | -5.41 M | -4.22 M | -2.25 M | -2.23 M | -1.75 M | -1.59 M |
| EPS (Basic) | -0.60 | -0.49 | -0.28 | -0.32 | -0.25 | -0.30 |
| EPS (Diluted) | -0.60 | -0.49 | -0.28 | -0.32 | -0.25 | -0.30 |
| Shares Outstanding | 9.01 M | 8.54 M | 7.97 M | 7.05 M | 7.02 M | 5.30 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.